Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

BACKGROUND: Colorectal cancer is the third most common cancer and a major cause of morbidity and mortality worldwide. Adjuvant chemotherapy is considered the standard of care in patients with UICC stage III colon cancer after R0 resection. Adjuvant therapy was not shown to be beneficial in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Teufel, Andreas, Gerken, Michael, Hartl, Janine, Itzel, Timo, Fichtner-Feigl, Stefan, Stroszczynski, Christian, Schlitt, Hans Jürgen, Hofstädter, Ferdinand, Klinkhammer-Schalke, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451874/
https://www.ncbi.nlm.nih.gov/pubmed/25985893
http://dx.doi.org/10.1186/s12885-015-1404-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451874/
https://www.ncbi.nlm.nih.gov/pubmed/25985893
http://dx.doi.org/10.1186/s12885-015-1404-9

Ejemplares similares